Inovio Biomedical (NYSE Amex: INO) is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines. A comprehensive description of Inovio, its product pipeline, and its leading More >>

INO (Common Stock) Exchange NYSE AMEX (US Dollar) Price $1.23 Change (%)   0.05 (4.24%) Volume 695,888 Data as of 02/08/10 3:59 p.m. ET Minimum 20 minute delay Refresh quote

Date Title   02/08/10 Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial 02/03/10 Inovio Biomedical to Present at BIO CEO & Investor Conference 01/27/10 Inovio Unveils Skin Electroporation Technology for Delivering DNA Vaccines 01/19/10 Inovio Biomedical to Present at Partnering and Vaccine Conferences

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Inovio Biomedical Corporation posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.